Autoimmune generalized myasthenia gravis is a disease that manifests with fluctuating muscle weakness. Inebilizumab is a monoclonal antibody that depletes CD19+ B cells, which are central to ...

Significantly, all of the autoantibodies directly disrupted the receptor's function as an ion channel. The findings challenge previous assumptions about how myasthenia gravis antibodies disrupt ...